• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.02% Nasdaq Up 0.44%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    14.37 Up 0.41(2.91%) 1:47PM EDT - Nasdaq Real Time Price
    Prev Close:13.96
    Open:14.04
    Bid:14.31 x 300
    Ask:14.33 x 300
    1y Target Est:17.50
    Beta:1.83147
    Next Earnings Date: 8-Aug-16CLVS Earnings announcement
    Day's Range:13.94 - 14.37
    52wk Range:11.57 - 116.75
    Volume:226,732
    Avg Vol (3m):1,008,730
    Market Cap:551.47M
    P/E (ttm):N/A
    EPS (ttm):-10.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CLVSUp 2.91%551.47M
    IMMU 0.00%250.28M
    THLDDown 3.15%37.34M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-8.00
    Quarterly EPS Est (Jun-16) :-2.13
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback